News

The new patent entitled, ‘Oligonucleotides for Treatment of Prostate and other Cancers,’ includes coverage for antisense and siRNA compositions that reduce the amount of active Heat Shock Protein

The transaction represents the second successful licensing agreement of a technology jointly developed between a CDRD-affiliated institution and CDRD, and the first between BCCA and CDRD. Irinophore C

TransVax is used for the prevention of reactivation of latent cytomegalovirus (CMV) or introduction of CMV through donor cells or tissues in transplant recipients. The vaccine is formulated

Takeda Bio Development Center (Takeda Bio), a wholly owned subsidiary of Takeda, has initiated the Japanese portion of the trial and will lead AMG 479’s development in Japan.

In December 1994, the International Society for Cellular Therapy (ISCT) and the American Society for Blood and Marrow Transplantation (ASBMT) merged their standards into a single document covering

The acquisition prodives RXi Pharma with to access NeuVax, a peptide-based immunotherapy for low-to-intermediate HER2+ breast cancer, patients who are not eligible for Herceptin RXi has targeted NeuVax

Under the agreement, Imperial College will take up the responsibility for VAL101’s late preclinical development. The aim is to provide validation for the GeneICE clinical applications and validation

RayVa is designed to be applied as a cream to fingers or toes, delivering alprostadil directly to the area of need, in order to stimulate blood flow. Apricus

As per the terms of the agreement, both the parties will together organize preclinical research. The collaboration will combine Amunix’s protein half-life engineering expertise, based on its proprietary